Organogenesis Holdings Statistics
Total Valuation
ORGO has a market cap or net worth of $211.03 million. The enterprise value is $231.88 million.
| Market Cap | 211.03M |
| Enterprise Value | 231.88M |
Important Dates
The last earnings date was Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ORGO has 128.67 million shares outstanding. The number of shares has decreased by -1.00% in one year.
| Current Share Class | 128.67M |
| Shares Outstanding | 128.67M |
| Shares Change (YoY) | -1.00% |
| Shares Change (QoQ) | +0.69% |
| Owned by Insiders (%) | 36.02% |
| Owned by Institutions (%) | 43.98% |
| Float | 61.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.46 |
| Forward PS | 0.96 |
| PB Ratio | 1.42 |
| P/TBV Ratio | 1.81 |
| P/FCF Ratio | 10.13 |
| P/OCF Ratio | 6.60 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 11.13 |
Financial Position
The company has a current ratio of 3.52, with a Debt / Equity ratio of 0.23.
| Current Ratio | 3.52 |
| Quick Ratio | 2.58 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 4.93 |
| Debt / FCF | 3.21 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -25.92% and return on invested capital (ROIC) is -8.51%.
| Return on Equity (ROE) | -25.92% |
| Return on Assets (ROA) | -4.11% |
| Return on Invested Capital (ROIC) | -8.51% |
| Return on Capital Employed (ROCE) | -8.15% |
| Weighted Average Cost of Capital (WACC) | 8.60% |
| Revenue Per Employee | $535,660 |
| Profits Per Employee | -$119,067 |
| Employee Count | 854 |
| Asset Turnover | 1.05 |
| Inventory Turnover | 4.19 |
Taxes
In the past 12 months, ORGO has paid $49.39 million in taxes.
| Income Tax | 49.39M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.53% in the last 52 weeks. The beta is 1.29, so ORGO's price volatility has been higher than the market average.
| Beta (5Y) | 1.29 |
| 52-Week Price Change | -66.53% |
| 50-Day Moving Average | 2.18 |
| 200-Day Moving Average | 3.12 |
| Relative Strength Index (RSI) | 32.93 |
| Average Volume (20 Days) | 912,338 |
Short Selling Information
The latest short interest is 14.23 million, so 11.06% of the outstanding shares have been sold short.
| Short Interest | 14.23M |
| Short Previous Month | 13.31M |
| Short % of Shares Out | 11.06% |
| Short % of Float | 23.31% |
| Short Ratio (days to cover) | 15.56 |
Income Statement
In the last 12 months, ORGO had revenue of $457.45 million and -$101.68 million in losses. Loss per share was -$0.80.
| Revenue | 457.45M |
| Gross Profit | 327.02M |
| Operating Income | -28.50M |
| Pretax Income | -34.77M |
| Net Income | -101.68M |
| EBITDA | -9.70M |
| EBIT | -28.50M |
| Loss Per Share | -$0.80 |
Balance Sheet
The company has $46.10 million in cash and $66.95 million in debt, with a net cash position of -$20.85 million or -$0.16 per share.
| Cash & Cash Equivalents | 46.10M |
| Total Debt | 66.95M |
| Net Cash | -20.85M |
| Net Cash Per Share | -$0.16 |
| Equity (Book Value) | 288.13M |
| Book Value Per Share | 1.15 |
| Working Capital | 143.34M |
Cash Flow
In the last 12 months, operating cash flow was $31.97 million and capital expenditures -$11.13 million, giving a free cash flow of $20.84 million.
| Operating Cash Flow | 31.97M |
| Capital Expenditures | -11.13M |
| Depreciation & Amortization | 18.80M |
| Net Borrowing | -10.79M |
| Free Cash Flow | 20.84M |
| FCF Per Share | $0.16 |
Margins
Gross margin is 71.49%, with operating and profit margins of -6.23% and -18.40%.
| Gross Margin | 71.49% |
| Operating Margin | -6.23% |
| Pretax Margin | -7.60% |
| Profit Margin | -18.40% |
| EBITDA Margin | -2.12% |
| EBIT Margin | -6.23% |
| FCF Margin | 4.56% |
Dividends & Yields
ORGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.00% |
| Shareholder Yield | 1.00% |
| Earnings Yield | -48.19% |
| FCF Yield | 9.88% |
Analyst Forecast
The average price target for ORGO is $2.00, which is 21.95% higher than the current price. The consensus rating is "Hold".
| Price Target | $2.00 |
| Price Target Difference | 21.95% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | -18.89% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ORGO has an Altman Z-Score of 3.29 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.29 |
| Piotroski F-Score | 3 |